BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
 
Delta Search Labs and Proteome Systems to explore the intersection of computational engineering and proteomics

Boston/Sydney - December 12, 2002. Delta Search Labs and Proteome Systems today announced a Memorandum of Understanding between the two companies to explore commercial opportunities at the intersection of computational engineering and proteomics.

Both parties intend to conduct an extensive review to leverage their respective technology platforms and expertise into joint development and commercialization opportunities in the life sciences.

“At Delta Search Labs, we believe that high-performance computing and advanced visualization will push performance in proteomics to a new level, and have been looking for a thought partner to help us realize our vision. The formation of Charles River Proteomics Services, a high-throughput proteomics contract services venture, has clearly established Proteome Systems as the preeminent technology player in this arena, and we could not have hoped for a better thought and commercialization partner”, said Kamal Jaffrey, CEO of Delta Search Labs.

“The relationship with Delta Search Labs grants us access to one of the world’s leading supercomputing and visualization laboratories and world-renowned experts in pattern recognition, image processing and data mining with high impact potential for proteomic technology. We are excited to have the opportunity to combine our knowledge of proteomics with Delta Search Labs’ computational skills for breakthrough results”, said Dr. Keith Williams, CEO of Proteome Systems.

About Proteome Systems

Proteome Systems is a leading proteomics technology, diagnostics and discovery company. With its technology partners, Proteome Systems has developed and commercialized a comprehensive solution for high throughput proteomics, which is available as a total solutions package, ProteomIQ™. These technologies, integrated by a proprietary  and sophisticated bioinformatics system, BioinformatIQ™, are being marketed as part of a global strategic alliance with IBM. ProteomIQ is implemented in Proteome Systems discovery programs in the areas of cystic fibrosis, cancer, infectious disease and aging. Proteome Systems has R&D and manufacturing facilities in Sydney, Australia and Boston, USA and a joint venture (Proteome Systems Japan) with Itochu Corporation in Tokyo, Japan. Proteome Systems recently formed a joint venture with Charles River Laboratories, Wilmington, USA (Charles River Proteomics Services Inc.) to provide contract services in proteomics.

For more information about the company, please go to www.proteomesystems.com.

BioinformatIQ, GlycomIQ and ProteomIQ are trademarks of Proteome Systems

About Delta Search Labs

Delta Search Labs is a privately funded problem-solving and idea realization facility dedicated to the creative exploitation of state-of-the-art supercomputer and visualization technologies. Delta Search Labs is focused on integrating world-class academic talent with industry experience and business expertise.  The collaboration of leading academics, industry experts, and seasoned project managers, combined with unhindered access to cutting-edge supercomputing and visualization capabilities gives Delta Search Labs a unique ability to add value to private enterprise and to work with clients and partners to push the boundaries in solving problems, addressing technical bottlenecks and shortcomings, and developing new products and services. For more information, visit www.deltasearchlabs.com.

For more information:

Kirsten Lodge, Corporate Communications
+61 2-9889-1830 (Kirsten.lodge@proteomesystems.com)

Andrew Gooley, Ph.D., Chief Scientific Officer, Proteome Systems Ltd.
+1 617.365.1645 (andrew.gooley@proteomesystems.com)

John Zhang, Ph.D., VP Engineering, Delta Search Labs
+1 617.551.4603 (jzhang@deltasearchlabs.com)

Kirsten Lodge
Corporate Communications
Proteome Systems Ltd

1/35-41 Waterloo Road
North Ryde NSW 2113
Locked Bag 2073
North Ryde NSW 1670
Australia

Direct ph: 61 2 8877 8913
Switch: 61 2 9889 1830
Fax: 61 2 9889 1805
Email: kirsten@proteomesystems.com
Website: www.proteomesystems.com

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.